BR112018072559A2 - método de tratar infecção do trato urinário. - Google Patents

método de tratar infecção do trato urinário.

Info

Publication number
BR112018072559A2
BR112018072559A2 BR112018072559-5A BR112018072559A BR112018072559A2 BR 112018072559 A2 BR112018072559 A2 BR 112018072559A2 BR 112018072559 A BR112018072559 A BR 112018072559A BR 112018072559 A2 BR112018072559 A2 BR 112018072559A2
Authority
BR
Brazil
Prior art keywords
urinary tract
treating urinary
tract infection
infection
treating
Prior art date
Application number
BR112018072559-5A
Other languages
English (en)
Inventor
L Manley Amy
L. TZANIS Evangelos
Garrity-Ryan Lynne
Ken TANAKA S.
N. STEENBERGEN Judith
Bai Stephen
Original Assignee
Paratek Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharmaceuticals, Inc. filed Critical Paratek Pharmaceuticals, Inc.
Publication of BR112018072559A2 publication Critical patent/BR112018072559A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a invenção divulgada provê um método para tratar infecção do trato urinário (uti) usando 9-[(2,2-dimetil-propilamino)-metil]-minociclina ou um sal da mesma, nas doses oral ou iv ou uma combinação de ambas.
BR112018072559-5A 2016-05-02 2017-05-02 método de tratar infecção do trato urinário. BR112018072559A2 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201662330436P 2016-05-02 2016-05-02
US62/330436 2016-05-02
US201662350332P 2016-06-15 2016-06-15
US62/350332 2016-06-15
US201662415988P 2016-11-01 2016-11-01
US62/415988 2016-11-01
US201662422852P 2016-11-16 2016-11-16
US62/422852 2016-11-16
PCT/US2017/030546 WO2017192516A1 (en) 2016-05-02 2017-05-02 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment

Publications (1)

Publication Number Publication Date
BR112018072559A2 true BR112018072559A2 (pt) 2019-02-19

Family

ID=60203337

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018072559-5A BR112018072559A2 (pt) 2016-05-02 2017-05-02 método de tratar infecção do trato urinário.

Country Status (13)

Country Link
US (2) US10238670B2 (pt)
EP (1) EP3452048A4 (pt)
JP (1) JP2019514952A (pt)
CN (1) CN109414445A (pt)
AU (1) AU2017259960A1 (pt)
BR (1) BR112018072559A2 (pt)
CA (1) CA3022936A1 (pt)
MX (1) MX2018013271A (pt)
PH (1) PH12018502297A1 (pt)
RU (1) RU2018140463A (pt)
SG (1) SG11201809561WA (pt)
TW (1) TW201806604A (pt)
WO (1) WO2017192516A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112008001301T5 (de) 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induktion einer physiologischen Dispersions-Antwort in Bakterien-Zellen in einem Biofilm
TWI746610B (zh) * 2016-08-03 2021-11-21 美商派瑞泰Ｓｐｖ２有限公司 9-胺甲基米諾四環素化合物及其用途
SG10201913599RA (en) 2016-11-01 2020-02-27 Paratek Pharm Innc 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
MA52980A (fr) * 2018-04-30 2021-04-28 Melinta Therapeutics Inc Procédés de traitement d'infections bactériennes à l'aide d'oritavancine
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3846805A4 (en) * 2018-09-04 2022-08-24 Paratek Pharmaceuticals, Inc. METHODS OF TREATING MYCOBACTERIAL INFECTIONS USING TETRACYCLINE COMPOUNDS
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
WO2024085926A2 (en) * 2022-06-30 2024-04-25 University Of Utah Research Foundation Compositions and methods of treating, preventing or inhibiting a facultative anaerobe infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
JP4738333B2 (ja) * 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
US20080261913A1 (en) * 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
WO2009111064A2 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
TW202332671A (zh) 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
RS54485B1 (en) * 2008-08-08 2016-06-30 Tetraphase Pharmaceuticals, Inc. C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS

Also Published As

Publication number Publication date
JP2019514952A (ja) 2019-06-06
US20170333455A1 (en) 2017-11-23
PH12018502297A1 (en) 2019-04-29
EP3452048A1 (en) 2019-03-13
WO2017192516A1 (en) 2017-11-09
EP3452048A4 (en) 2019-11-13
AU2017259960A1 (en) 2018-12-06
SG11201809561WA (en) 2018-11-29
CA3022936A1 (en) 2017-11-09
MX2018013271A (es) 2019-03-28
US20190175625A1 (en) 2019-06-13
US10238670B2 (en) 2019-03-26
RU2018140463A (ru) 2020-06-03
CN109414445A (zh) 2019-03-01
TW201806604A (zh) 2018-03-01

Similar Documents

Publication Publication Date Title
BR112018072559A2 (pt) método de tratar infecção do trato urinário.
CL2018002359A1 (es) Métodos para usar agonistas de fxr
BR112017002332A2 (pt) terapia de combinação para o tratamento de um paramixovírus
BR112017001162A2 (pt) métodos para tratar paramixovírus
BR112018070602A2 (pt) composto, composição farmacêutica, uso do composto, e, método para tratar uma doença ou distúrbio
CR20190124A (es) Inhibidores de ssao de aminopirimidina
MX2019006821A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos.
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
CR20170315A (es) Inhibridores bace 1 selectivos
CL2012002422A1 (es) Método para tratar artritis por lupus activo que comprende administrar al paciente laquinimod o su sal sódica por vía oral.
SI3220916T1 (sl) Postopek zdravljenja raka z n-((4,6-dimetil-2-okso-1,2-dihidropiridin-3 -il)metil)-5-(etil(tetrahidro-2h-piran-4-il) amino)-4-metil-4'- (morfolinometil)-(1,1'-bifenil)-3-karboksamidom
DOP2017000071A (es) Terapia de combinación para alzheimer que usa anticuerpos anti-n3pglu a beta mas un inhibidor de bace.
BR112016022593A2 (pt) composições e métodos para modular a expressão do fator b do complemento
EP3970712A3 (en) Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof
BR112019007576A2 (pt) compostos de bifenil sulfonamida para o tratamento de doenças ou transtornos renais
MY174010A (en) Device for extracorporeal blood treatment
BR112019002730A2 (pt) acetil-leucina, ou um sal farmaceuticamente aceitável da mesma, para uso em um método de tratamento de uma doença neurodegenetativa
AR107990A1 (es) Formulación granulada de 5-metil-1-fenil-2-(1h)-piridona y método para elaborarla
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
BR112017028140A2 (pt) formulações farmacêuticas
CY1114757T1 (el) Παραγωγα οξαζινης και η χρηση τους στη θεραπεια νευρολογικων διαταραχων
BR112017008496A2 (pt) compostos para uso em tratamento antelmíntico
BR112016017620A2 (pt) Composto esteroidal para uso no tratamento da encefalopatia hepática
EP3405211A4 (en) ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASES

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]